CA2321757C - Intravenous cardiac lead with positive fixation segment - Google Patents
Intravenous cardiac lead with positive fixation segment Download PDFInfo
- Publication number
- CA2321757C CA2321757C CA002321757A CA2321757A CA2321757C CA 2321757 C CA2321757 C CA 2321757C CA 002321757 A CA002321757 A CA 002321757A CA 2321757 A CA2321757 A CA 2321757A CA 2321757 C CA2321757 C CA 2321757C
- Authority
- CA
- Canada
- Prior art keywords
- lead
- shape configuration
- preformed shape
- lead body
- end portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 17
- 238000001990 intravenous administration Methods 0.000 title abstract description 3
- 210000003462 vein Anatomy 0.000 claims abstract description 35
- 210000003748 coronary sinus Anatomy 0.000 claims abstract description 14
- 239000004020 conductor Substances 0.000 claims description 37
- 229920000642 polymer Polymers 0.000 claims description 11
- 230000017531 blood circulation Effects 0.000 claims description 4
- 230000033764 rhythmic process Effects 0.000 claims 7
- 210000005245 right atrium Anatomy 0.000 claims 7
- 230000002792 vascular Effects 0.000 abstract description 3
- 238000006073 displacement reaction Methods 0.000 abstract description 2
- 230000003511 endothelial effect Effects 0.000 abstract description 2
- 238000002513 implantation Methods 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 6
- 238000007493 shaping process Methods 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N2001/0585—Coronary sinus electrodes
Abstract
An intravenous lead for use with a cardiac device for implantation in the coronary venous system of the heart includes a lead body (10) that is adapted to be routed through the vascular system into the coronary sinus with the distal end portion of the lead placed in the great cardiac vein (12) or branch vein. The lead body (10) includes a preformed section disposed just proximal of its tip so that the lead body exhibits a two-dimensional wave having peaks (22), and valleys (24) for contacting the endothelial layer of the vein (12) at discrete, longitudinally spaced points to stabilize the electrode (20) against displacement.
Description
INTRAVENOUS CARDIAC LEAD ~nTITH
POSITIVE FIXATION SEGMENT
BACKGROUND OF THE INVENTION
I. Field of the Invention: This invention relates 5 generally to a cardiac pacing lead designed for placement in a coronary vein, and more particularly to such a lead employing a preformed shape in a distal end portion thereof for holding the distal end portion of the pacing lead carrying the stimulating electrode in place and for IO increased lead flexibility.
II. Discussion of the Prior Art: Cardiac pacemakers for treating bradycardia commonly employ pacing leads for connecting an electrical pulse generator to excitable cardiac tissue, usually within the heart's right ventricle.
15 Such leads have one or more electrodes proximate the distal end thereof and also commonly employ tines located just distal of the tip electrode for holding that electrode in contact with endocardial tissue in the right ventricle.
The tines engage the trabeculae, resisting movement of the 20 lead tip due to body movement and/or contractions of the heart muscle itself.
More recently, researchers have found that cardiac stimulation can have a beneficial effect in treating patients suffering from congestive heart failure (CHF). By 25 properly controlling the AV interval of the pacemaker, a sick heart may be made to pump more efficiently. Pacing therapy for the treatment of CHF, however, often requires the ability to stimulate the left ventricle, either alone or in conjunction with right ventricular stimulation.
30 Current methods for achieving left ventricular pacing require placement of an epicardial lead, via thoracotomy or a thoracoscopic approach. Because of the usual poor condition of CHF patients, both of these procedures are "high risk" due to the trauma of the surgery itself and the 35 need for general anesthesia. To obviate the need for a thoracotomy, left ventricular access (LVA) leads have been developed that may be introduced through the coronary sinus and then advanced through the coronary veins so that the lead's stimulating electrode can be positioned on the surface of the left ventricle near the apex of the heart.
Those skilled in the art knowing the anatomical configuration and dimensions of the coronary veins on the heart can appreciate that a lead to be routed therethrough must be of a relatively small diameter as compared to a conventional pacing lead adapted for placement in the right ventricle. Heart motion and respiratory motion as well as blood blow or other body movement are typical mechanisms for lead dislodgment . As such, a means must be provided for at least temporarily anchoring the electrode at a desired selected location until tissue ingrowth and resulting lead stabilization occurs. Additionally, a means must be provided to decouple the relative motion of the heart from the distal tip of the lead thereby reducing trauma to the coronary vein and neighboring myocardium.
These problems are deemed to be more acute in CHF patients due to the dilated condition of CHF hearts and general diseased state of the tissue.
It can be seen, then, that a need exists for a pacing lead that can readily be advanced through the coronary sinus and thence through a coronary vein on the heart and having an anchoring and stress-relieving structure for safely maintaining the electrode at a desired site notwithstanding heart motion, respiratory motion blood flow and other body movement.
SUNJHIARY OF THE INVENTION
The present invention comprises an implantable lead for placement in a selected coronary vein. It includes a lead body with at least one electrode carried thereon at a distal end portion thereof and an elongated conductor contained within the lead body electrically joining a terminal pin at a proximal end of the lead body to the electrode at its distal end. To temporarily anchor the distal end portion of the lead body within the selected coronary vein until such time that tissue ingrowth can be relied upon for retention, the lead includes a distal end portion exhibiting a wave-like configuration with a plurality of longitudinally spaced peaks and valleys such that the lead body engages the vein wall at discrete points 5 for inhibiting displacement of the electrode because of body movement, respiratory movement, beating action of the heart and flow of blood in the vein occupied by the lead.
Additionally, the wave-like configuration adds resiliency to the lead body thereby reducing the dislodgment forces 10 transmitted to the electrode and causing less injury to the vessel.
DESCRIPTION OF THE DRAWINGS
Figure 1 is a side elevational view of a left coronary pacing lead, the distal end portion being shown within the 15 lumen of a distal portion of coronary vein;
Figure 2 is a cross-sectional view of the lead of Figure 1 taken along the line 2-2 in Figure 1;
Figure 3 is a cross-sectional view taken along the line 3-3 in Figure 2;
20 Figure 4 is a greatly enlarged view of a segment of the distal end portion of the lead of Figure l;
Figure 5 is a cross-sectional view taken along line 5 5 in Figure 1 showing an alternative lead construction; and Figure 6 is a greatly enlarged view of a segment of 25 the distal end portion of the lead of Figure 1 incorporating an external shaping member; and Figure 7 is an enlarged longitudinal cross-sectional view of a portion of the lead body with an internal shaping member.
30 DESCRIPTION OF THE PREFERRED ~ODIMENT
Referring to Figure 1, there is indicated generally by numeral 10 a pacing lead specifically designed to be routed through the coronary sinus and into the great cardiac vein or branch vein, traversing the epicardium of the left 35 ventricle. A segment of vein is identified by numeral 12.
The lead preferably comprises an elongated flexible outer insulating polymer jacket 14 that surrounds an inner, helically wound conductor 16. The conductor 16 extends the full length of the lead from its proximal terminal pin 18 to an electrode 20 affixed near the distal end of the lead body.
POSITIVE FIXATION SEGMENT
BACKGROUND OF THE INVENTION
I. Field of the Invention: This invention relates 5 generally to a cardiac pacing lead designed for placement in a coronary vein, and more particularly to such a lead employing a preformed shape in a distal end portion thereof for holding the distal end portion of the pacing lead carrying the stimulating electrode in place and for IO increased lead flexibility.
II. Discussion of the Prior Art: Cardiac pacemakers for treating bradycardia commonly employ pacing leads for connecting an electrical pulse generator to excitable cardiac tissue, usually within the heart's right ventricle.
15 Such leads have one or more electrodes proximate the distal end thereof and also commonly employ tines located just distal of the tip electrode for holding that electrode in contact with endocardial tissue in the right ventricle.
The tines engage the trabeculae, resisting movement of the 20 lead tip due to body movement and/or contractions of the heart muscle itself.
More recently, researchers have found that cardiac stimulation can have a beneficial effect in treating patients suffering from congestive heart failure (CHF). By 25 properly controlling the AV interval of the pacemaker, a sick heart may be made to pump more efficiently. Pacing therapy for the treatment of CHF, however, often requires the ability to stimulate the left ventricle, either alone or in conjunction with right ventricular stimulation.
30 Current methods for achieving left ventricular pacing require placement of an epicardial lead, via thoracotomy or a thoracoscopic approach. Because of the usual poor condition of CHF patients, both of these procedures are "high risk" due to the trauma of the surgery itself and the 35 need for general anesthesia. To obviate the need for a thoracotomy, left ventricular access (LVA) leads have been developed that may be introduced through the coronary sinus and then advanced through the coronary veins so that the lead's stimulating electrode can be positioned on the surface of the left ventricle near the apex of the heart.
Those skilled in the art knowing the anatomical configuration and dimensions of the coronary veins on the heart can appreciate that a lead to be routed therethrough must be of a relatively small diameter as compared to a conventional pacing lead adapted for placement in the right ventricle. Heart motion and respiratory motion as well as blood blow or other body movement are typical mechanisms for lead dislodgment . As such, a means must be provided for at least temporarily anchoring the electrode at a desired selected location until tissue ingrowth and resulting lead stabilization occurs. Additionally, a means must be provided to decouple the relative motion of the heart from the distal tip of the lead thereby reducing trauma to the coronary vein and neighboring myocardium.
These problems are deemed to be more acute in CHF patients due to the dilated condition of CHF hearts and general diseased state of the tissue.
It can be seen, then, that a need exists for a pacing lead that can readily be advanced through the coronary sinus and thence through a coronary vein on the heart and having an anchoring and stress-relieving structure for safely maintaining the electrode at a desired site notwithstanding heart motion, respiratory motion blood flow and other body movement.
SUNJHIARY OF THE INVENTION
The present invention comprises an implantable lead for placement in a selected coronary vein. It includes a lead body with at least one electrode carried thereon at a distal end portion thereof and an elongated conductor contained within the lead body electrically joining a terminal pin at a proximal end of the lead body to the electrode at its distal end. To temporarily anchor the distal end portion of the lead body within the selected coronary vein until such time that tissue ingrowth can be relied upon for retention, the lead includes a distal end portion exhibiting a wave-like configuration with a plurality of longitudinally spaced peaks and valleys such that the lead body engages the vein wall at discrete points 5 for inhibiting displacement of the electrode because of body movement, respiratory movement, beating action of the heart and flow of blood in the vein occupied by the lead.
Additionally, the wave-like configuration adds resiliency to the lead body thereby reducing the dislodgment forces 10 transmitted to the electrode and causing less injury to the vessel.
DESCRIPTION OF THE DRAWINGS
Figure 1 is a side elevational view of a left coronary pacing lead, the distal end portion being shown within the 15 lumen of a distal portion of coronary vein;
Figure 2 is a cross-sectional view of the lead of Figure 1 taken along the line 2-2 in Figure 1;
Figure 3 is a cross-sectional view taken along the line 3-3 in Figure 2;
20 Figure 4 is a greatly enlarged view of a segment of the distal end portion of the lead of Figure l;
Figure 5 is a cross-sectional view taken along line 5 5 in Figure 1 showing an alternative lead construction; and Figure 6 is a greatly enlarged view of a segment of 25 the distal end portion of the lead of Figure 1 incorporating an external shaping member; and Figure 7 is an enlarged longitudinal cross-sectional view of a portion of the lead body with an internal shaping member.
30 DESCRIPTION OF THE PREFERRED ~ODIMENT
Referring to Figure 1, there is indicated generally by numeral 10 a pacing lead specifically designed to be routed through the coronary sinus and into the great cardiac vein or branch vein, traversing the epicardium of the left 35 ventricle. A segment of vein is identified by numeral 12.
The lead preferably comprises an elongated flexible outer insulating polymer jacket 14 that surrounds an inner, helically wound conductor 16. The conductor 16 extends the full length of the lead from its proximal terminal pin 18 to an electrode 20 affixed near the distal end of the lead body.
5 In accordance with the present invention, a portion of the lead body located just proximal of the distal electrode 20 is preformed to exhibit a wave-like appearance defining a plurality of peaks 22 and valleys 24 which lie substantially in one plane. With no limitation intended, 10 the outer jacket 14 of the lead body may have a O.D. in the range of from about 3 Fr to 5 Fr (0.039-0.065 in.) and the wave-like portion may be located proximally from the lead tip and may span a zone about 4-7 centimeters in length.
The peak-to-peak amplitude of the undulations in the lead 15 body might typically be in a range of from 0.5-4.0 centimeters.
The amplitude and frequency of the wave shape is intended to cause the lead 10 to make intermittent contact with the wall of the vein 12. The force exerted on the 20 vessel wall by the built-in bias property provides resistance to extraction forces attributable to heart motion, respiratory motion and blood flow in the vasculature. The resiliency imparted to the lead by the wave shape absorbs heart and respiratory motion forces, 25 thereby decoupling the mechanisms of dislodgement from the distal end of the lead. Both attributes of the built-in bias act to stabilize the electrode in its initial implant position without injury or damage to the vessel or underlying myocardium.
30 The wave-like shape may be imparted to the lead by preforming the conductor coil 16 prior to the application of the polymer jacket 14 so that when the lead is unconstrained, the distal end portion will assume the wave-like configuration. Alternatively, the bias may be 35 imparted to the lead in a zone near its distal end by selective molding of the insulating polymer jacket 14 over the coiled conductor 16.
With the conductor 16 being helically wound, it defines an internal lumen 26. The shape-biased lead is preferably implanted by tracking over a guidewire passed through the tubular terminal pin 18 and through the lumen 5 26 of the lead body. The guidewire overcomes the bias built into the lead and effectively straightens out the wave comprising the retention portion of the lead as it is being routed through the vascular system, the coronary sinus and into the great cardiac vein and branch vein.
10 Alternatively, a stiff stylet may be used to straighten out the bias for routing through the coronary vascular system.
Once the electrode 20 is positioned at a desired site, the guidewire or stiffening stylet is withdrawn, allowing the built-in bias to restore the wave-like shape to the 15 anchoring portion of the lead so that it will engage the walls of the coronary vein at each peak and valley.
An enhancement of the above-described concept is illustrated in Figure 4. Here, a stiffening element 28 is added at discrete, spaced-apart locations within the wave-20 like shape imparted to the lead body. The stiffening elements 28 are disposed on the helical wound conductor and may be composed of , for example, thin-walled heat shrink PTFE tubing. These tubing segments 28 increase the contact force between the lead body and the blood vessel wall 12, 25 causing the reinforced bends to function as anchoring points as previously described while other bends not reinforced with the shrink-tubing function to decouple movements of the lead body from displacing the electrode 20 from its desired stimulating site.
30 A further embodiment of the present invention is shown in Figure 5 and comprises a lead having a braided cable conductor with an adjacent lumen 32 extending along side it from the distal tip to the terminal pin and of sufficient size to accept a guidewire or stiffening stylet therein.
35 Wave-like shapes can be imparted to such a lead by means of premolded portions of the lead body as previously explained with the aid of Figure 4 by including shaping elements within the lead body, such as an external shaping coil as at 34 in Figure 6 or an internal shaping coil as at 36 in Figure 7 or even a premolded polymer shaping element as at 38 in Figure 5.
5 A distinct advantage of the present invention resides in the intermittent points of the contact between the lead body and the vessel wall. This offers an advantage over prior art coronary sinus leads, such as that described in the Ayers Patent 5,476,498. The Ayers lead has a helical 10 bias that places the lead body in substantial contact with the wall of the great cardiac vein or coronary sinus over the length of the helix. Experiments have shown that a lead in contact with the vessel wall elicits a histological response that encapsulates and attaches the lead to the 15 endothelial wall of the blood vessel in which it is placed.
The helical fixation places a substantial surface in contact and greatly complicates any chance of using standard removal techniques should it become necessary to explant the lead. In dog experiments which have been 20 conducted, it has been demonstrated that a "saw-tooth" wave bias tends only to elicit encapsulation at the intermittent points of contact with the vessel wall, thereby reducing the degree of involvement and, hence, facilitating lead removal following histological maturation.
25 This invention has been described herein in considerable detail in order to comply with the patent statutes and to provide those skilled in the art with the information needed to apply the novel principles and to construct and use such specialized components as are 30 required. However, it is to be understood that the invention can be carried out by specifically different equipment and devices, and that various modifications, both as to the equipment and operating procedures, can be accomplished without departing from the scope of the 35 invention itself.
What is claimed is:
The peak-to-peak amplitude of the undulations in the lead 15 body might typically be in a range of from 0.5-4.0 centimeters.
The amplitude and frequency of the wave shape is intended to cause the lead 10 to make intermittent contact with the wall of the vein 12. The force exerted on the 20 vessel wall by the built-in bias property provides resistance to extraction forces attributable to heart motion, respiratory motion and blood flow in the vasculature. The resiliency imparted to the lead by the wave shape absorbs heart and respiratory motion forces, 25 thereby decoupling the mechanisms of dislodgement from the distal end of the lead. Both attributes of the built-in bias act to stabilize the electrode in its initial implant position without injury or damage to the vessel or underlying myocardium.
30 The wave-like shape may be imparted to the lead by preforming the conductor coil 16 prior to the application of the polymer jacket 14 so that when the lead is unconstrained, the distal end portion will assume the wave-like configuration. Alternatively, the bias may be 35 imparted to the lead in a zone near its distal end by selective molding of the insulating polymer jacket 14 over the coiled conductor 16.
With the conductor 16 being helically wound, it defines an internal lumen 26. The shape-biased lead is preferably implanted by tracking over a guidewire passed through the tubular terminal pin 18 and through the lumen 5 26 of the lead body. The guidewire overcomes the bias built into the lead and effectively straightens out the wave comprising the retention portion of the lead as it is being routed through the vascular system, the coronary sinus and into the great cardiac vein and branch vein.
10 Alternatively, a stiff stylet may be used to straighten out the bias for routing through the coronary vascular system.
Once the electrode 20 is positioned at a desired site, the guidewire or stiffening stylet is withdrawn, allowing the built-in bias to restore the wave-like shape to the 15 anchoring portion of the lead so that it will engage the walls of the coronary vein at each peak and valley.
An enhancement of the above-described concept is illustrated in Figure 4. Here, a stiffening element 28 is added at discrete, spaced-apart locations within the wave-20 like shape imparted to the lead body. The stiffening elements 28 are disposed on the helical wound conductor and may be composed of , for example, thin-walled heat shrink PTFE tubing. These tubing segments 28 increase the contact force between the lead body and the blood vessel wall 12, 25 causing the reinforced bends to function as anchoring points as previously described while other bends not reinforced with the shrink-tubing function to decouple movements of the lead body from displacing the electrode 20 from its desired stimulating site.
30 A further embodiment of the present invention is shown in Figure 5 and comprises a lead having a braided cable conductor with an adjacent lumen 32 extending along side it from the distal tip to the terminal pin and of sufficient size to accept a guidewire or stiffening stylet therein.
35 Wave-like shapes can be imparted to such a lead by means of premolded portions of the lead body as previously explained with the aid of Figure 4 by including shaping elements within the lead body, such as an external shaping coil as at 34 in Figure 6 or an internal shaping coil as at 36 in Figure 7 or even a premolded polymer shaping element as at 38 in Figure 5.
5 A distinct advantage of the present invention resides in the intermittent points of the contact between the lead body and the vessel wall. This offers an advantage over prior art coronary sinus leads, such as that described in the Ayers Patent 5,476,498. The Ayers lead has a helical 10 bias that places the lead body in substantial contact with the wall of the great cardiac vein or coronary sinus over the length of the helix. Experiments have shown that a lead in contact with the vessel wall elicits a histological response that encapsulates and attaches the lead to the 15 endothelial wall of the blood vessel in which it is placed.
The helical fixation places a substantial surface in contact and greatly complicates any chance of using standard removal techniques should it become necessary to explant the lead. In dog experiments which have been 20 conducted, it has been demonstrated that a "saw-tooth" wave bias tends only to elicit encapsulation at the intermittent points of contact with the vessel wall, thereby reducing the degree of involvement and, hence, facilitating lead removal following histological maturation.
25 This invention has been described herein in considerable detail in order to comply with the patent statutes and to provide those skilled in the art with the information needed to apply the novel principles and to construct and use such specialized components as are 30 required. However, it is to be understood that the invention can be carried out by specifically different equipment and devices, and that various modifications, both as to the equipment and operating procedures, can be accomplished without departing from the scope of the 35 invention itself.
What is claimed is:
Claims (114)
1. A lead for a cardiac rhythm management device, the lead having a distal end and a proximal end, the lead comprising:
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, the at least one peak and at least one valley for engaging a wall of the coronary vein to assist in holding the electrode relatively fixed in position irrespective of forces due to body movements and blood flow.
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, the at least one peak and at least one valley for engaging a wall of the coronary vein to assist in holding the electrode relatively fixed in position irrespective of forces due to body movements and blood flow.
2. The lead according to claim 1, wherein the preformed shape configuration lies in substantially the same plane.
3. The lead according to claim 1, wherein the preformed shape configuration is configured to straighten out when the guidewire is passed through the lumen.
4. The lead according to claim 1, wherein the lumen is configured to receive a stylet for routing the lead.
5. The lead according to claim 4, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
6. The lead according to claim 1, wherein an outer diameter of the lead body is about 5 Fr.
7. The lead according to claim 1, wherein the preformed shape configuration spans a zone of about 4 centimeters.
8. The lead according to claim 1, wherein the at least one peak and the at least one valley includes a series of peaks and valleys forming a wave shaped portion of the lead body.
9. The lead according to claim 1, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween.
10. The lead according to claim 1, wherein the at least one peak and valley form at least one "S" shaped portion of the lead body.
11. The lead according to claim 10, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
12. The lead according to claim 1, wherein the preformed shape configuration is located immediately proximal to the electrode.
13. The lead according to claim 12, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
14. The lead according to claim 13, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
15. The lead according to claim 14, wherein the unstraightened length is about centimeters.
16. The lead according to claim 1, wherein the conductor includes a helically wound portion.
17. The lead according to claim 16, wherein the conductor imparts the preformed shape configuration to the lead body.
18. The lead according to claim 16, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
19. The lead according to claim 1, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
20. A lead for a cardiac rhythm management device, the lead having a distal end and a proximal end, the lead comprising:
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least a first curved portion and a second curved portion.
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least a first curved portion and a second curved portion.
21. The lead according to claim 20, wherein the preformed shape configuration lies in substantially the same plane.
22. The lead according to claim 20, wherein the preformed shape configuration is configured to straighten out when the guidewire is passed through the lumen.
23. The lead according to claim 20, wherein the lumen is configured to receive a stylet for routing the lead.
24. The lead according to claim 23, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
25. The lead according to claim 20, wherein an outer diameter of the lead body is about 5 Fr.
26. The lead according to claim 20, wherein the preformed shape configuration spans a zone of about 4 centimeters.
27. The lead according to claim 20, wherein the preformed shape configuration further includes a third and a fourth curved portion, the first, second, third, and fourth curved portions forming a wave shaped portion of the lead body.
28. The lead according to claim 20, wherein the first curved portion and the second curved portion define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween.
29. The lead according to claim 20, wherein the first and second curved portions form at least one "S" shaped portion of the lead body.
30. The lead according to claim 29, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
31. The lead according to claim 20, wherein the preformed shape configuration is located immediately proximal to the electrode.
32. The lead according to claim 31, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
33. The lead according to claim 32, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
34. The lead according to claim 33, wherein the unstraightened length is about centimeters.
35. The lead according to claim 20, wherein the conductor includes a helically wound portion.
36. The lead according to claim 35, wherein the conductor imparts the preformed shape configuration to the lead body.
37. The lead according to claim 35, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
38. The lead according to claim 20, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
39. A cardiac rhythm management device selected from at least one of a pacemaker and a defibrillator, the device comprising:
a lead having a distal end and a proximal end, the lead further comprising:
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least a first curved portion and a second curved portion; and a power source electrically coupled to the conductor for providing power to the electrode.
a lead having a distal end and a proximal end, the lead further comprising:
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least a first curved portion and a second curved portion; and a power source electrically coupled to the conductor for providing power to the electrode.
40. The device according to claim 39, wherein the preformed shape configuration lies in substantially the same plane.
41. The device according to claim 39, wherein the preformed shape configuration is configured to straighten out when the guidewire is passed through the lumen.
42. The device according to claim 39, wherein the lumen is configured to receive a stylet for routing the lead.
43. The device according to claim 42, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
44. The device according to claim 39, wherein an outer diameter of the lead body is about 5 Fr.
45. The device according to claim 39, wherein the preformed shape configuration spans a zone of about 4 centimeters.
46. The device according to claim 39, wherein the preformed shape configuration further includes a third and a fourth curved portion, the first, second, third, and fourth curved portions forming a wave shaped portion of the lead body.
47. The device according to claim 39, wherein the first curved portion and the second curved portion define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween.
48. The device according to claim 39, wherein the first and second curved portions form at least one "S" shaped portion of the lead body.
49. The device according to claim 48, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
50. The device according to claim 39, wherein the preformed shape configuration is located immediately proximal to the electrode.
51. The device according to claim 50, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
52. The device according to claim 51, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
53. The device according to claim 52, wherein the unstraightened length is about 4 centimeters.
54. The device according to claim 39, wherein the conductor includes a helically wound portion.
55. The device according to claim 54, wherein the conductor imparts the preformed shape configuration to the lead body.
56. The device according to claim 54, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
57. The device according to claim 39, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
58. A lead for a cardiac rhythm management device, comprising:
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion, and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, and an outer diameter of the lead body being about 5 Fr.
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion, and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, and an outer diameter of the lead body being about 5 Fr.
59. The lead according to claim 58, wherein the preformed shape configuration lies in substantially the same plane.
60. The lead according to claim 58, wherein the preformed shape configuration is configured to straighten out when a guidewire is passed through the lumen.
61. The lead according to claim 58, wherein the lumen is configured to receive a stylet for routing the lead.
62. The lead according to claim 61, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
63. The lead according to claim 58, wherein the preformed shape configuration spans a zone of about 4 centimeters.
64. The lead according to claim 58, wherein the at least one peak and the at least one valley includes a series of peaks and valleys forming a wave shaped portion of the lead body.
65. The lead according to claim 58, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween.
66. The lead according to claim 58, wherein the at least one peak and valley form at least one "S" shaped portion of the lead body.
67. The lead according to claim 66, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
68. The lead according to claim 58, wherein the preformed shape configuration is located immediately proximal to the electrode.
69. The lead according to claim 68, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
70. The lead according to claim 69, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
71. The lead according to claim 70, wherein the unstraightened length is about centimeters.
72. The lead according to claim 58, wherein the conductor includes a helically wound portion.
73. The lead according to claim 72, wherein the conductor imparts the preformed shape configuration to the lead body.
74. The lead according to claim 72, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
75. The lead according to claim 58, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
76. A lead for a cardiac rhythm management device, comprising:
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween and the preformed shape configuration extends over a length from about 4 to 20 centimeters, and an outer diameter of the lead body being about 5 Fr.
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween and the preformed shape configuration extends over a length from about 4 to 20 centimeters, and an outer diameter of the lead body being about 5 Fr.
77. The lead according to claim 76, wherein the preformed shape configuration lies in substantially the same plane.
78. The lead according to claim 76, wherein the preformed shape configuration is configured to straighten out when a guidewire is passed through the lumen.
79. The lead according to claim 76, wherein the lumen is configured to receive a stylet for routing the lead.
80. The lead according to claim 79, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
81. The lead according to claim 76, wherein the preformed shape configuration spans a zone of about 4 centimeters.
82. The lead according to claim 76, wherein the at least one peak and the at least one valley includes a series of peaks and valleys forming a wave shaped portion of the lead body.
83. The lead according to claim 76, wherein the at least one peak and valley form at least one "S" shaped portion of the lead body.
84. The lead according to claim 83, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
85. The lead according to claim 76, wherein the preformed shape configuration is located immediately proximal to the electrode.
86. The lead according to claim 85, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
87. The lead according to claim 86, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
88. The lead according to claim 87, wherein the unstraightened length is about centimeters.
89. The lead according to claim 76, wherein the conductor includes a helically wound portion.
90. The lead according to claim 89, wherein the conductor imparts the preformed shape configuration to the lead body.
91. The lead according to claim 89, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
92. The lead according to claim 76, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
93. A lead for a cardiac rhythm management device, comprising:
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one "S" shaped portion, the "S" shaped portion spanning a zone of about 4 centimeters and having an amplitude in a range from about 0.5 to 4.0 centimeters, and an outer diameter of the lead body being about 5 Fr.
an elongated, flexible insulating lead body having a proximal end portion, a distal end portion and a lumen; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and a coronary vein of the heart, the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one "S" shaped portion, the "S" shaped portion spanning a zone of about 4 centimeters and having an amplitude in a range from about 0.5 to 4.0 centimeters, and an outer diameter of the lead body being about 5 Fr.
94. The lead according to claim 93, wherein the preformed shape configuration lies in substantially the same plane.
95. The lead according to claim 93, wherein the preformed shape configuration is configured to straighten out when a guidewire is passed through the lumen.
96. The lead according to claim 93, wherein the lumen is configured to receive a stylet for routing the lead.
97. The lead according to claim 96, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet.
98. The lead according to claim 93, wherein the at least one "S" shaped portion includes a plurality of "S" shaped portions of the lead body.
99. The lead according to claim 93, wherein the preformed shape configuration is located immediately proximal to the electrode.
100. The lead according to claim 99, wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
101. The lead according to claim 100, wherein the preformed shaped configuration extends over a length of about 4 to 20 centimeters.
102. The lead according to claim 93, wherein the conductor includes a helically wound portion.
103. The lead according to claim 102, wherein the conductor imparts the preformed shape configuration to the lead body.
104. The lead according to claim 102, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
105. The lead according to claim 93, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
106. A lead for a cardiac rhythm management device, the lead having a distal end and a proximal end, the lead comprising:
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire and alternatively a stylet, such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire or such that the stylet can route the lead to the coronary vein; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, the at least one peak and at least one valley for engaging a wall of the coronary vein to assist in holding the electrode relatively fixed in position irrespective of forces due to body movements and blood flow, wherein the preformed shape configuration is configured to straighten out when the guidewire is passed through the lumen, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet, wherein an outer diameter of the lead body is about 5 Fr, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween, wherein the preformed shape configuration is located immediately proximal to the electrode, and wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
an elongated, flexible insulating lead body having a proximal end portion and a distal end portion;
a lumen located between the proximal end of the lead and the distal end of the lead and capable of receiving a guidewire and alternatively a stylet, such that the guidewire may be passed through the lumen so that the lead may be implanted into a coronary vein by tracking over the guidewire or such that the stylet can route the lead to the coronary vein; and an electrode attached to the lead body at the distal end portion, the lead body including a conductor extending from the proximal end portion of the lead body to the electrode, and the lead body being sized to permit the distal end portion to be advanced through the right atrium and into a coronary sinus and the coronary vein of the heart, and the lead body having a section with a preformed shape configuration, the preformed shape configuration located at the distal end portion of the lead body and having at least one peak and at least one valley, the at least one peak and at least one valley for engaging a wall of the coronary vein to assist in holding the electrode relatively fixed in position irrespective of forces due to body movements and blood flow, wherein the preformed shape configuration is configured to straighten out when the guidewire is passed through the lumen, wherein the preformed shape configuration is configured to straighten out upon receipt of the stylet, wherein an outer diameter of the lead body is about 5 Fr, wherein the at least one peak and the at least one valley define an amplitude in a range from about 0.5 to 4.0 centimeters therebetween, wherein the preformed shape configuration is located immediately proximal to the electrode, and wherein the lead body includes a relatively straight proximal section and wherein the preformed shape configuration is located immediately distal to the straight proximal section.
107. The lead according to claim 106, wherein the preformed shape configuration lies in substantially the same plane.
108. The lead according to claim 106, wherein the preformed shape configuration spans a zone of about 4 centimeters.
109. The lead according to claim 106, wherein the preformed shape configuration has an unstraightened length of about 4 to 7 centimeters.
110. The lead according to claim 109, wherein the unstraightened length is about 4 centimeters.
111. The lead according to claim 106, wherein the conductor includes a helically wound portion.
112. The lead according to claim 111, wherein the conductor imparts the preformed shape configuration to the lead body.
113. The lead according to claim 111, wherein the open center of the helically wound conductor is of a size to receive a straightening member therein.
114. The lead according to claim 106, wherein the lead body includes a polymer jacket configured to impart the preformed shape configuration.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/027,821 US5925073A (en) | 1998-02-23 | 1998-02-23 | Intravenous cardiac lead with wave shaped fixation segment |
| US09/027,821 | 1998-02-23 | ||
| PCT/US1999/002891 WO1999042170A1 (en) | 1998-02-23 | 1999-02-11 | Intravenous cardiac lead with positive fixation segment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2321757A1 CA2321757A1 (en) | 1999-08-26 |
| CA2321757C true CA2321757C (en) | 2006-04-11 |
Family
ID=21839969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002321757A Expired - Fee Related CA2321757C (en) | 1998-02-23 | 1999-02-11 | Intravenous cardiac lead with positive fixation segment |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5925073A (en) |
| EP (1) | EP1056507B1 (en) |
| AT (1) | ATE310563T1 (en) |
| CA (1) | CA2321757C (en) |
| DE (1) | DE69928498T2 (en) |
| WO (1) | WO1999042170A1 (en) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6556862B2 (en) | 1998-03-19 | 2003-04-29 | Cardiac Pacemakers, Inc. | Method and apparatus for treating supraventricular tachyarrhythmias |
| US6134478A (en) | 1998-06-05 | 2000-10-17 | Intermedics Inc. | Method for making cardiac leads with zone insulated electrodes |
| US6240320B1 (en) | 1998-06-05 | 2001-05-29 | Intermedics Inc. | Cardiac lead with zone insulated electrodes |
| US6463334B1 (en) | 1998-11-02 | 2002-10-08 | Cardiac Pacemakers, Inc. | Extendable and retractable lead |
| US6501990B1 (en) | 1999-12-23 | 2002-12-31 | Cardiac Pacemakers, Inc. | Extendable and retractable lead having a snap-fit terminal connector |
| US7313444B2 (en) * | 1998-11-20 | 2007-12-25 | Pacesetter, Inc. | Self-anchoring coronary sinus lead |
| US6129750A (en) * | 1999-03-23 | 2000-10-10 | Cardiac Pacemakers, Inc. | Fixation mechanism for a coronary venous pacing lead |
| US6363287B1 (en) | 1999-10-27 | 2002-03-26 | Medtronic, Inc. | Steroid elution electrodes LVCV, left atrial medical/elecrical leads |
| US6549812B1 (en) | 1999-11-29 | 2003-04-15 | Medtronic, Inc. | Medical electrical lead having bending stiffness which increase in the distal direction |
| US6556873B1 (en) | 1999-11-29 | 2003-04-29 | Medtronic, Inc. | Medical electrical lead having variable bending stiffness |
| US6574512B1 (en) | 2000-08-28 | 2003-06-03 | Cardiac Pacemakers, Inc. | Lead system with main lead and transverse lead |
| US6493586B1 (en) | 2000-08-30 | 2002-12-10 | Cardiac Pacemakers, Inc. | Site reversion in cardiac rhythm management |
| US6584362B1 (en) * | 2000-08-30 | 2003-06-24 | Cardiac Pacemakers, Inc. | Leads for pacing and/or sensing the heart from within the coronary veins |
| US6697676B2 (en) | 2000-12-21 | 2004-02-24 | Medtronic, Inc. | Medical electrical lead having an expandable electrode assembly |
| US6480740B2 (en) * | 2000-12-26 | 2002-11-12 | Cardiac Pacemakers, Inc. | Safety pacing in multi-site CRM devices |
| US7033326B1 (en) | 2000-12-29 | 2006-04-25 | Advanced Bionics Corporation | Systems and methods of implanting a lead for brain stimulation |
| US7177701B1 (en) | 2000-12-29 | 2007-02-13 | Advanced Bionics Corporation | System for permanent electrode placement utilizing microelectrode recording methods |
| DE10114725A1 (en) * | 2001-03-21 | 2002-09-26 | Biotronik Mess & Therapieg | Intravascular lead |
| US6711443B2 (en) | 2001-07-25 | 2004-03-23 | Oscor Inc. | Implantable coronary sinus lead and method of implant |
| US6738674B2 (en) | 2001-07-25 | 2004-05-18 | Oscor Inc. | Implantable coronary sinus lead with mapping capabilities |
| KR100428551B1 (en) * | 2001-12-04 | 2004-04-28 | 삼성광주전자 주식회사 | Method for manufacturing crank shaft of hermetic reciprocating compressor |
| US6973351B2 (en) * | 2002-03-19 | 2005-12-06 | Pacesetter, Inc. | Leads using composite materials for conductors and stylet insertion for improved handling characteristics in lead implantation performance |
| US20030203704A1 (en) * | 2002-04-30 | 2003-10-30 | Roger Dahl | Apparatus and method for implanting an electrical lead |
| US6968237B2 (en) * | 2002-05-22 | 2005-11-22 | Pacesetter, Inc. | Implantable coronary sinus lead and lead system |
| US6988007B1 (en) | 2002-08-13 | 2006-01-17 | Pacesetter, Inc. | Single pass telescoping cardiac lead for the left heart |
| US7392094B2 (en) * | 2002-12-19 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable lead for septal placement of pacing electrodes |
| US7555351B2 (en) * | 2002-12-19 | 2009-06-30 | Cardiac Pacemakers, Inc. | Pulmonary artery lead for atrial therapy and atrial pacing and sensing |
| US7890188B2 (en) * | 2002-12-19 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable lead for septal placement of electrode with fixation mechanism in the pulmonary artery |
| US20040122498A1 (en) * | 2002-12-19 | 2004-06-24 | Yongxing Zhang | Pulmonary artery lead for atrial therapy |
| US20040243210A1 (en) * | 2003-05-30 | 2004-12-02 | Morgan Kevin L. | Fixation of a left heart medical lead in the coronary sinus |
| WO2005025401A2 (en) * | 2003-09-09 | 2005-03-24 | Board Of Regents | Method and apparatus for determining cardiac performance in a patient with a conductance catheter |
| US20050080472A1 (en) * | 2003-10-10 | 2005-04-14 | Atkinson Robert Emmett | Lead stabilization devices and methods |
| US7212869B2 (en) * | 2004-02-04 | 2007-05-01 | Medtronic, Inc. | Lead retention means |
| DE102004036397A1 (en) * | 2004-07-23 | 2006-02-09 | Biotronik Vi Patent Ag | Stimulation electrode lead |
| US7395120B2 (en) * | 2004-08-13 | 2008-07-01 | The General Hospital Corporation | Telescoping, dual-site pacing lead |
| US20060036306A1 (en) * | 2004-08-13 | 2006-02-16 | Heist E K | Telescoping, dual-site pacing lead |
| US20060041297A1 (en) * | 2004-08-23 | 2006-02-23 | Medtronic, Inc. | Novel electrode assembly for medical electrical leads |
| US8219212B2 (en) * | 2004-08-23 | 2012-07-10 | Medtronic, Inc. | Distal portions for medical electrical leads |
| US20060089694A1 (en) * | 2004-10-21 | 2006-04-27 | Cardiac Pacemakers, Inc. | Delivery system and method for pulmonary artery leads |
| US7308319B2 (en) * | 2004-10-21 | 2007-12-11 | Cardiac Pacemakers, Inc. | Delivery system and method using pulmonary artery for placement of RV leads |
| US7809446B2 (en) * | 2005-01-05 | 2010-10-05 | Boston Scientific Neuromodulation Corporation | Devices and methods for brain stimulation |
| US7783359B2 (en) * | 2005-01-05 | 2010-08-24 | Boston Scientific Neuromodulation Corporation | Devices and methods using an implantable pulse generator for brain stimulation |
| US20060276868A1 (en) * | 2005-06-03 | 2006-12-07 | Seth Worley | Coronary sinus lead for pacing the left atrium |
| US20060276869A1 (en) * | 2005-06-03 | 2006-12-07 | Seth Worley | Coronary sinus lead for pacing the left atrium |
| US8271094B1 (en) | 2005-09-30 | 2012-09-18 | Boston Scientific Neuromodulation Corporation | Devices with cannula and electrode lead for brain stimulation and methods of use and manufacture |
| US7747334B2 (en) * | 2006-03-23 | 2010-06-29 | Cardiac Pacemakers, Inc. | Left ventricular lead shapes |
| US8442656B2 (en) * | 2006-06-02 | 2013-05-14 | Cardiac Pacemakers, Inc. | Cardiac lead having implantable stiffening structures for fixation |
| US20070282413A1 (en) * | 2006-06-02 | 2007-12-06 | Cardiac Pacemakers, Inc. | Cardiac lead having stiffening structures for fixation |
| US7865248B2 (en) * | 2006-06-15 | 2011-01-04 | Cardiac Pacemakers, Inc. | Biasing and fixation features on leads |
| US20070293923A1 (en) * | 2006-06-15 | 2007-12-20 | Cardiac Pacemakers, Inc. | Lead with orientation feature |
| US7583999B2 (en) | 2006-07-31 | 2009-09-01 | Cranial Medical Systems, Inc. | Multi-channel connector for brain stimulation system |
| US7765015B2 (en) * | 2007-01-12 | 2010-07-27 | Cardiac Pacemakers, Inc. | Lead with inflatable fixation mechanism |
| US20100198041A1 (en) * | 2007-04-27 | 2010-08-05 | Christian Steven C | Apparatus and method for positioning and retention of catheter |
| US8103359B2 (en) * | 2007-05-17 | 2012-01-24 | Cardiac Pacemakers, Inc. | Systems and methods for fixating transvenously implanted medical devices |
| WO2008149289A2 (en) * | 2007-06-04 | 2008-12-11 | Koninklijke Philips Electronics, N.V. | Insertion system and lead for treatment of a target tissue region |
| US20090088827A1 (en) * | 2007-10-02 | 2009-04-02 | Cardiac Pacemakers, Inc | Lead assembly providing sensing or stimulation of spaced-apart myocardial contact areas |
| US8391985B2 (en) * | 2009-11-30 | 2013-03-05 | Boston Scientific Neuromodulation Corporation | Electrode array having concentric windowed cylinder electrodes and methods of making the same |
| US8295944B2 (en) * | 2009-11-30 | 2012-10-23 | Boston Scientific Neuromodulation Corporation | Electrode array with electrodes having cutout portions and methods of making the same |
| EP2559453B1 (en) | 2011-08-18 | 2014-07-16 | Sorin CRM SAS | Lead implantable in the coronary vessels for multi-zone stimulation of a left heart chamber |
| WO2013047015A1 (en) * | 2011-09-28 | 2013-04-04 | テルモ株式会社 | Lead-securing means and medical device |
| US20150306375A1 (en) | 2014-04-25 | 2015-10-29 | Medtronic, Inc. | Implantable extravascular electrical stimulation lead having improved sensing and pacing capability |
| US10532206B2 (en) | 2014-10-24 | 2020-01-14 | Medtronic, Inc. | Coronary sinus medical electrical lead |
| US10016591B2 (en) | 2014-10-24 | 2018-07-10 | Medtronic, Inc. | Medical electrical lead |
| WO2016065345A1 (en) * | 2014-10-24 | 2016-04-28 | Medtronic, Inc. | Coronary sinus medical electrical lead |
| US9901732B2 (en) | 2014-10-24 | 2018-02-27 | Medtronic, Inc. | Medical electrical lead |
| WO2016094470A1 (en) * | 2014-12-09 | 2016-06-16 | Medtronic, Inc. | Extravascular implantable electrical lead having undulating configuration |
| US9682239B2 (en) | 2015-02-06 | 2017-06-20 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| SG10201602007WA (en) | 2015-04-20 | 2016-11-29 | Biotronik Se & Co Kg | Implantable curved shaping part for externally shaping an implantable electrode line or a catheter |
| SG10201602009PA (en) | 2015-04-20 | 2016-11-29 | Biotronik Se & Co Kg | Implantable curved shaping part for externally shaping an implantable electrode line or a catheter |
| AU2016355338B2 (en) | 2015-11-20 | 2019-04-18 | Cardiac Pacemakers, Inc. | Single pass coronary venous lead for multiple chamber sense and pace |
| EP3600536B1 (en) | 2017-03-20 | 2021-06-16 | Cardiac Pacemakers, Inc. | Leadless pacing device for treating cardiac arrhythmias |
| US11160989B2 (en) | 2017-03-20 | 2021-11-02 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| US10994148B2 (en) | 2017-03-20 | 2021-05-04 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| CN110430920B (en) | 2017-03-20 | 2023-10-27 | 心脏起搏器股份公司 | Leadless pacing device for treating cardiac arrhythmias |
| WO2019126295A1 (en) | 2017-12-22 | 2019-06-27 | Cardiac Pacemakers, Inc. | Implantable medical device for vascular deployment |
| WO2019126281A1 (en) | 2017-12-22 | 2019-06-27 | Cardiac Pacemakers, Inc. | Implantable medical device for vascular deployment |
| US11291833B2 (en) | 2018-05-09 | 2022-04-05 | Medtronic, Inc. | Bonding strip for fixing an electrode coil to a lead body |
| AU2019222842A1 (en) | 2018-09-10 | 2020-03-26 | Northern Development AS | Percutaneous Lead |
| EP3946556A1 (en) | 2019-03-29 | 2022-02-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| EP3946568A1 (en) | 2019-03-29 | 2022-02-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| WO2021050685A1 (en) | 2019-09-11 | 2021-03-18 | Cardiac Pacemakers, Inc. | Tools and systems for implanting and/or retrieving a leadless cardiac pacing device with helix fixation |
| JP2022547306A (en) | 2019-09-11 | 2022-11-11 | カーディアック ペースメイカーズ， インコーポレイテッド | Devices and systems for implanting and/or withdrawing leadless cardiac pacing devices using helical fixation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9203735D0 (en) * | 1992-12-11 | 1992-12-11 | Siemens Elema Ab | ELECTRIC SYSTEM FOR DEFIBRILLATOR |
| US5387233A (en) * | 1993-01-11 | 1995-02-07 | Incontrol, Inc. | Intravenous cardiac lead with improved fixation and method |
| US5405374A (en) * | 1993-08-25 | 1995-04-11 | Medtronic, Inc. | Transvenous defibrillation lead and method of use |
| US5456707A (en) * | 1993-10-22 | 1995-10-10 | Vitatron Medical Bv | Pacing lead with improved torsion characteristics |
| US5846223A (en) * | 1993-11-03 | 1998-12-08 | Daig Corporation | Diagnosis and treatment of atrial flutter in the right atrium |
| US5476498A (en) * | 1994-08-15 | 1995-12-19 | Incontrol, Inc. | Coronary sinus channel lead and method |
| US5772693A (en) * | 1996-02-09 | 1998-06-30 | Cardiac Control Systems, Inc. | Single preformed catheter configuration for a dual-chamber pacemaker system |
| US5683445A (en) * | 1996-04-29 | 1997-11-04 | Swoyer; John M. | Medical electrical lead |
-
1998
- 1998-02-23 US US09/027,821 patent/US5925073A/en not_active Expired - Lifetime
-
1999
- 1999-02-11 AT AT99905929T patent/ATE310563T1/en active
- 1999-02-11 EP EP99905929A patent/EP1056507B1/en not_active Expired - Lifetime
- 1999-02-11 WO PCT/US1999/002891 patent/WO1999042170A1/en active IP Right Grant
- 1999-02-11 CA CA002321757A patent/CA2321757C/en not_active Expired - Fee Related
- 1999-02-11 DE DE69928498T patent/DE69928498T2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2321757A1 (en) | 1999-08-26 |
| US5925073A (en) | 1999-07-20 |
| EP1056507B1 (en) | 2005-11-23 |
| WO1999042170A1 (en) | 1999-08-26 |
| EP1056507A1 (en) | 2000-12-06 |
| ATE310563T1 (en) | 2005-12-15 |
| EP1056507A4 (en) | 2004-07-21 |
| DE69928498T2 (en) | 2006-07-20 |
| DE69928498D1 (en) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2321757C (en) | Intravenous cardiac lead with positive fixation segment | |
| US6201994B1 (en) | Single pass lead and method of use | |
| US6556873B1 (en) | Medical electrical lead having variable bending stiffness | |
| EP1017447B1 (en) | Medical electrical lead | |
| US5800497A (en) | Medical electrical lead with temporarily stiff portion | |
| US5423865A (en) | Electrode system for a defibrillator | |
| US5755765A (en) | Pacing lead having detachable positioning member | |
| EP1363697B1 (en) | Coronary veins lead for pacing or sensing | |
| US7499757B2 (en) | Absorbable myocardial lead fixation system | |
| US6178356B1 (en) | Coronary venous lead having fixation mechanism | |
| US6549812B1 (en) | Medical electrical lead having bending stiffness which increase in the distal direction | |
| US6129749A (en) | Monorail left ventricular access lead | |
| US6321123B1 (en) | J-shaped coronary sinus lead | |
| US4481953A (en) | Endocardial lead having helically wound ribbon electrode | |
| US6772015B2 (en) | Bifurcated lead system for a cardiac vein | |
| EP0504297B1 (en) | Steroid eluting intramuscular lead | |
| US5086787A (en) | Steroid eluting intramuscular lead | |
| US20070293923A1 (en) | Lead with orientation feature | |
| CA2050620A1 (en) | Multiple electrode deployable lead | |
| WO1997036639A1 (en) | Single-pass a-v pacing lead | |
| EP0954240A1 (en) | Side access "over the wire" pacing lead | |
| US6301507B1 (en) | Medical electrical lead having pre-formed atrial section |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20140211 |